BridgeMD
Umbilical vein catheterization through Wharton’s jelly in the delivery room : CaDOm multicenter clinical trial.
EU CTIS ID: 2024-515249-41-00
What this study is testing
Estimate the success rate of cardiopulmonary resuscitation in less than 90 seconds with the VOW procedure as first intention, in newborns with circulatory arrest in the delivery room for whom an adrenaline injection is indicated
- Phase II and Phase III (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Full-term newborn (≥ 37 weeks of Amenorrhea)
- Newborn for whom a decision to resuscitate has been made
- Newborn in circulatory arrest, or in deep bradycardia < 60 bpm, requiring an injection of adrenaline in the delivery room, the indication being made according to the recommendations of the ERC (European Ressuscitation Council) 2021, after completion of the first cardiopulmonary resuscitation steps, including establishment of effective ventilation
- Newborn beneficiary of a social security system or entitled to
- Parents or holders of parental authority aged 18 and over
You likely can't join if
- Newborn with known heart malformation, or another potentially lethal malformation
- Presence of an approach already laid
- Pediatric resuscitator not trained in the VOW method
- Twins born with circulatory arrest requiring simultaneous care
- Parents or holders of parental authority with cognitive impairments that prevent them from understanding the study
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.